Managed Account Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

Managed Account Advisors’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	$15.6M	Sell	88,829 -361	-0.4%	-$64.8K	0.01%	846
2015 Q1	$15.4M	Sell	89,190 -2,273	-2%	-$390K	0.01%	864
2014 Q4	$15M	Sell	91,463 -7,329	-7%	-$1.22M	0.01%	844
2014 Q3	$15.9M	Sell	98,792 -13,987	-12%	-$2.15M	0.02%	781
2014 Q2	$16.6M	Buy	112,779 +43,854	+64%	+$6.08M	0.02%	763
2014 Q1	$9.56M	Sell	68,925 -31,110	-31%	-$4.68M	0.01%	989
2013 Q4	$12.7M	Sell	100,035 -3,416	-3%	-$353K	0.02%	848
2013 Q3	$9.51M	Buy	103,451 +67,383	+187%	+$5.44M	0.01%	934
2013 Q2	$2.48M	Buy	+36,068	New	+$2.2M	﹤0.01%	1534

Other funds holding JAZZ

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

WBC

Westpac Banking Corp Sydney, Australia $1.44B AUM 28.5% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Managed Account Advisors's JAZZ Position: Q2 2015 in Review

Managed Account Advisors reduced its Jazz Pharmaceuticals (JAZZ) stake by 0.4% in Q2 2015, selling an estimated $64.8K and leaving 88,829 shares worth $15.6M. The position accounts for 0.01% of the portfolio, ranked #846.

Managed Account Advisors first reported a position in JAZZ in Q2 2013 and has held it in 9 quarters since. The position peaked at $16.6M in Q2 2014. 373 funds tracked by Wall St. Rank hold JAZZ as of Q2 2015.

Managed Account Advisors held 88,829 shares of Jazz Pharmaceuticals worth $15.6M as of Q2 2015.
Managed Account Advisors sold 361 Jazz Pharmaceuticals shares in Q2 2015, an estimated $64.8K.
Jazz Pharmaceuticals made up 0.01% of Managed Account Advisors's portfolio in Q2 2015, its #846 holding.
Managed Account Advisors first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 9 quarters since.
Managed Account Advisors's Jazz Pharmaceuticals position peaked at $16.6M in Q2 2014.
373 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.